https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Wed, 25 Aug 2021 11:22:50 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png https://mirror.vjregenmed.com 32 32 https://mirror.vjregenmed.com/video/gls6dvmtvpm-car-hematotox-predictive-model-of-hematotoxicity-after-car-t-cell-treatment/ Fri, 26 Feb 2021 14:08:23 +0000 http://13.40.107.223/video/gls6dvmtvpm-car-hematotox-predictive-model-of-hematotoxicity-after-car-t-cell-treatment/ Kai Rejeski, MD, LMU Hospital Munich, Munich, Germany, talks on CAR T-cell associated hematotoxicity in patients treated in the real-world setting. CD19-specific CAR T-cells have revolutionized the treatment of relapsed/refractory B-cell malignancies. Yet, their clinical success is associated with unique toxicities such as prolonged cytopenias. The identification of potential biomarkers that could be detected prior to CAR T-cell therapy would help understand which patients are at risk. Dr Rejeski discusses the score his group developed, the CAR-HEMATOTOX, to model hematotoxicity and highlights its clinical applications. This interview took place during the 3rd European CAR T-cell Meeting.

]]>